BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allen AJ, Ali SM, Gowen K, Elvin JA, Pejovic T. A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1. Gynecol Oncol Rep 2017;20:51-3. [PMID: 28331900 DOI: 10.1016/j.gore.2017.03.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Dermawan JK, Dashti N, Chiang S, Turashvili G, Dickson BC, Ellenson LH, Kirchner M, Stenzinger A, Mechtersheimer G, Agaimy A, Antonescu CR. Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners. Genes Chromosomes Cancer 2023;62:152-60. [PMID: 36445224 DOI: 10.1002/gcc.23109] [Reference Citation Analysis]
2 Zhu T, Zhang F, Yan H, Yu W, Chen M, Guan Y. A novel CDKN1A-JAZF1 gene fusion in low-grade endometrial stromal sarcoma arising from endometriosis in abdominal wall cesarean section scar: A case report and literature review. Taiwanese Journal of Obstetrics and Gynecology 2022;61:1082-1085. [DOI: 10.1016/j.tjog.2022.04.010] [Reference Citation Analysis]
3 de Almeida BC, Dos Anjos LG, Dobroff AS, Baracat EC, Yang Q, Al-Hendy A, Carvalho KC. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. Biomedicines 2022;10:2567. [PMID: 36289829 DOI: 10.3390/biomedicines10102567] [Reference Citation Analysis]
4 Rodriguez Pena MDC, Mubeen A, Harada S, Prieto Granada CN. An Unusual Benign Uterine Stromal Spindle Cell Tumor Harboring JAZF1::BCORL1. Int J Gynecol Pathol 2022. [PMID: 35838627 DOI: 10.1097/PGP.0000000000000894] [Reference Citation Analysis]
5 Kommoss FKF, Chiang S, Köbel M, Koelsche C, Chang KT, Irving JA, Dickson B, Thiryayi S, Rouzbahman M, Rasty G, von Deimling A, Lee CH, Turashvili G. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications. Am J Surg Pathol 2022. [PMID: 35499168 DOI: 10.1097/PAS.0000000000001909] [Reference Citation Analysis]
6 Mayr D, Horn L, Hiller GGR, Höhn AK, Schmoeckel E. Endometriale und weitere seltene uterine Sarkome. Pathologe 2022;43:183-195. [DOI: 10.1007/s00292-022-01072-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wei Q, Mackinnon AC, Siegal GP, Harada S. The diagnostic utility of RNA-based fusion panel testing ordered by pathologists in challenging cases. Annals of Diagnostic Pathology 2022. [DOI: 10.1016/j.anndiagpath.2022.151957] [Reference Citation Analysis]
8 Singh N, Zeke A, Reményi A. Systematic Discovery of FBXW7-Binding Phosphodegrons Highlights Mitogen-Activated Protein Kinases as Important Regulators of Intracellular Protein Levels. IJMS 2022;23:3320. [DOI: 10.3390/ijms23063320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chiang S. Mesenchymal Tumors, Pathology of the Uterine Corpus. Encyclopedia of Pathology 2022. [DOI: 10.1007/978-3-319-28845-1_5626-1] [Reference Citation Analysis]
10 Yamaguchi K. Personalized Treatment in Uterine Sarcoma. Personalization in Gynecologic Oncology 2022. [DOI: 10.1007/978-981-19-4711-7_4] [Reference Citation Analysis]
11 Niu S, Zheng W. Endometrial stromal tumors: Diagnostic updates and challenges. Seminars in Diagnostic Pathology 2022. [DOI: 10.1053/j.semdp.2022.01.004] [Reference Citation Analysis]
12 Li C, Wang C. LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies. J Zhejiang Univ Sci B 2021;22:633-46. [PMID: 34414699 DOI: 10.1631/jzus.B2000797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lin DI, Huang RSP, Mata DA, Decker B, Danziger N, Lechpammer M, Hiemenz M, Ramkissoon SH, Ross JS, Elvin JA. Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas. Mod Pathol 2021. [PMID: 34302054 DOI: 10.1038/s41379-021-00873-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
14 Sudarshan D, Avvakumov N, Lalonde M, Alerasool N, Joly-beauparlant C, Jacquet K, Mameri A, Lambert J, Rousseau J, Lachance C, Paquet E, Herrmann L, Setty ST, Loehr J, Bernardini MQ, Rouzbahman M, Gingras A, Coulombe B, Droit A, Taipale M, Doyon Y, Côté J. Recurrent chromosomal translocations in sarcomas create a mega-complex that mislocalizes NuA4/TIP60 to Polycomb target loci.. [DOI: 10.1101/2021.03.26.436670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Akaev I, Yeoh CC, Rahimi S. Update on Endometrial Stromal Tumours of the Uterus. Diagnostics (Basel) 2021;11:429. [PMID: 33802452 DOI: 10.3390/diagnostics11030429] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
16 Micci F, Heim S, Panagopoulos I. Molecular pathogenesis and prognostication of "low-grade'' and "high-grade" endometrial stromal sarcoma. Genes Chromosomes Cancer 2021;60:160-7. [PMID: 33099834 DOI: 10.1002/gcc.22907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
17 Momeni-Boroujeni A, Mohammad N, Wolber R, Yip S, Köbel M, Dickson BC, Hensley ML, Leitao MM Jr, Antonescu CR, Benayed R, Ladanyi M, Lee CH, Chiang S. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma. Mod Pathol 2021;34:1008-16. [PMID: 33077922 DOI: 10.1038/s41379-020-00705-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
18 Muthukumarana V, Fix DJ, Stolnicu S, Park KJ, Soslow RA, Benayed R, Ladanyi M, Antonescu CR, Chiang S. BCOR Expression in Mullerian Adenosarcoma: A Potential Diagnostic Pitfall. Am J Surg Pathol 2020;44:765-70. [PMID: 32011345 DOI: 10.1097/PAS.0000000000001445] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
19 Brahmi M, Franceschi T, Treilleux I, Pissaloux D, Ray-Coquard I, Dufresne A, Vanacker H, Carbonnaux M, Meeus P, Sunyach MP, Bouhamama A, Karanian M, Meurgey A, Blay JY, Tirode F. Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural History. Cancers (Basel) 2020;12:E2604. [PMID: 32933053 DOI: 10.3390/cancers12092604] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
20 Libertini M, Hallin M, Thway K, Noujaim J, Benson C, van der Graaf W, Jones RL. Gynecological Sarcomas: Molecular Characteristics, Behavior, and Histology-Driven Therapy. Int J Surg Pathol 2021;29:4-20. [PMID: 32909482 DOI: 10.1177/1066896920958120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Alabiad MA, Harb OA, Abdelfattah MT, El-shafaay BS, El-taher AK, El-hendawy EI. The values of Transgelin, Stathmin, BCOR and Cyclin-D1 expression in differentiation between Uterine Leiomyosarcoma (ULMS) and Endometrial Stromal Sarcoma (ESS); diagnostic and prognostic implications. Surg Exp Pathol 2020;3. [DOI: 10.1186/s42047-020-00065-0] [Reference Citation Analysis]
22 Zou Y, Turashvili G, Soslow RA, Park KJ, Croce S, McCluggage WG, Stewart CJR, Oda Y, Oliva E, Young RH, Da Cruz Paula A, Dessources K, Ashley CW, Hensley ML, Yip S, Weigelt B, Benayed R, Antonescu CR, Lee CH, Chiang S. High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities. Mod Pathol 2020;33:1861-70. [PMID: 32317704 DOI: 10.1038/s41379-020-0535-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
23 McEvoy CR, Fox SB, Prall OWJ. Emerging entities in NUTM1-rearranged neoplasms. Genes Chromosomes Cancer 2020;59:375-85. [PMID: 32060986 DOI: 10.1002/gcc.22838] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
24 Micci F, Davidson B. Molecular Genetics of Uterine Sarcomas. eLS 2019. [DOI: 10.1002/9780470015902.a0028464] [Reference Citation Analysis]
25 Dickson BC, Sung YS, Rosenblum MK, Reuter VE, Harb M, Wunder JS, Swanson D, Antonescu CR. NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors. Am J Surg Pathol 2018;42:636-45. [PMID: 29356724 DOI: 10.1097/PAS.0000000000001021] [Cited by in Crossref: 61] [Cited by in F6Publishing: 74] [Article Influence: 15.3] [Reference Citation Analysis]
26 Dickson BC. Beyond Smooth Muscle-Other Mesenchymal Neoplasms of the Uterus. Surg Pathol Clin 2019;12:107-37. [PMID: 30709439 DOI: 10.1016/j.path.2018.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Ferreira J, Félix A, Lennerz JK, Oliva E. Recent advances in the histological and molecular classification of endometrial stromal neoplasms. Virchows Arch 2018;473:665-78. [DOI: 10.1007/s00428-018-2470-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
28 Tuyaerts S, Amant F. Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy. Vaccines (Basel) 2018;6:E56. [PMID: 30149610 DOI: 10.3390/vaccines6030056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
29 Dickson BC, Lum A, Swanson D, Bernardini MQ, Colgan TJ, Shaw PA, Yip S, Lee CH. Novel EPC1 gene fusions in endometrial stromal sarcoma. Genes Chromosomes Cancer 2018;57:598-603. [PMID: 30144186 DOI: 10.1002/gcc.22649] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
30 Gantzer J, Ray-coquard I. Gynecological sarcomas: what's new in 2018, a brief review of published literature. Current Opinion in Oncology 2018;30:246-51. [DOI: 10.1097/cco.0000000000000462] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
31 Hoang L, Chiang S, Lee C. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. Pathology 2018;50:162-77. [DOI: 10.1016/j.pathol.2017.11.086] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 13.6] [Reference Citation Analysis]
32 Wojcik J, Cooper K. Epigenetic Alterations in Bone and Soft Tissue Tumors. Adv Anat Pathol 2017;24:362-71. [PMID: 28885261 DOI: 10.1097/PAP.0000000000000167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
33 Micci F, Brunetti M, Dal Cin P, Nucci MR, Gorunova L, Heim S, Panagopoulos I. Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma. Genes Chromosomes Cancer 2017;56:841-5. [PMID: 28758277 DOI: 10.1002/gcc.22485] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 5.2] [Reference Citation Analysis]
34 Vroobel KM, Karawita TS, Wilkinson N. New developments in endometrial stromal sarcoma. Diagnostic Histopathology 2017;23:311-22. [DOI: 10.1016/j.mpdhp.2017.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]